Middle East respiratory syndrome (MERS) is a viral respiratory illness caused by the Middle East respiratory syndrome coronavirus (MERS-CoV). MERS is typically spread between animals and people.

Whether combined treatment with recombinant interferon beta-1b and lopinavir–ritonavir reduces mortality among patients hospitalized with Middle East respiratory syndrome (MERS) is unclear.

The Middle East respiratory syndrome is caused by a coronavirus that was first identified in Saudi Arabia in 2012. Periodic outbreaks continue to occur in the Middle East and elsewhere. This report ...

Patients with Middle East Respiratory Syndrome (MERS) develop more severe critical illness and have higher mortality than patients with non-MERS severe acute respiratory infection (SARI ...

Middle East respiratory syndrome coronavirus (MERS-CoV) causes high fever, cough, acute respiratory tract infection and multiorgan dysfunction that may eventually lead to the death of the infected ...

Middle East respiratory syndrome (MERS) has recently returned to the headlines as new cases have been exported to Korea and China. Experts are concerned that MERS cases continued to be detected in ...

Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging virus, with the first case reported in 2012. It exhibits a 40% fatality rate and over 97% of the cases have occurred in the ...

New estimates of the transmissibility of the Middle East respiratory syndrome coronavirus in humans suggest that it does not yet have pandemic potential, according to research published in The Lancet.

The new Middle East Respiratory Syndrome strain was diagnosed in Saudi Arabia last year. It is a coronavirus, the same viral family that triggered the outbreak of SARS, Severe Acute Respiratory ...